Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii
Clinical trials sponsored by Fundación Centro Nacional De Investigaciones Cardiovasculares Carlos Iii, explained in plain language.
-
Simple arm cuff may shield lymphoma Patients' hearts from chemo damage
Prevention Recruiting nowThis study tests a simple, non-invasive procedure called Remote Ischemic PreConditioning (RIPC) to see if it can prevent heart damage in lymphoma patients receiving anthracycline chemotherapy. About 608 adults with lymphoma or breast cancer who are at risk for heart problems will…
Phase: NA • Sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III • Aim: Prevention
Last updated May 02, 2026 15:33 UTC
-
Could a common painkiller calm heart inflammation?
Symptom relief Recruiting nowThis study tests if a 3-week course of ibuprofen (an anti-inflammatory drug) can reduce heart muscle inflammation better than standard pain relief (acetaminophen) in people hospitalized with acute myocarditis. About 150 adults with mild heart inflammation and normal pumping funct…
Phase: PHASE3 • Sponsor: Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III • Aim: Symptom relief
Last updated May 02, 2026 15:32 UTC